These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23370238)

  • 1. Mike Yeadon. Interview with Charlotte Harrison.
    Yeadon M
    Nat Rev Drug Discov; 2013 Feb; 12(2):96. PubMed ID: 23370238
    [No Abstract]   [Full Text] [Related]  

  • 2. Robert Stoll. Interview by Charlotte Harrison.
    Stoll R
    Nat Rev Drug Discov; 2009 Dec; 8(12):926. PubMed ID: 19949397
    [No Abstract]   [Full Text] [Related]  

  • 3. IV. Recent medicine legislation in the United Kingdom and its effect on manufacturing practice.
    Fishburn AG
    Bull Parenter Drug Assoc; 1974; 28(4):174-80. PubMed ID: 4852607
    [No Abstract]   [Full Text] [Related]  

  • 4. The FDA's critical path initiative: a brief introduction.
    Coons SJ
    Clin Ther; 2009 Nov; 31(11):2572-3. PubMed ID: 20110002
    [No Abstract]   [Full Text] [Related]  

  • 5. Patents: a threat to innovation?
    Manocaran M
    Science; 2010 Jan; 327(5961):31-2; author reply 32. PubMed ID: 20044557
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs and the relationships between university, industry and legislation.
    Calin A
    Drugs Exp Clin Res; 1987; 13(11):685-7. PubMed ID: 3443044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations on the discovery and supply of medicines.
    Weatherall M
    Proc R Soc Med; 1974 Dec; 67(12 Pt 2):1287-92. PubMed ID: 4449879
    [No Abstract]   [Full Text] [Related]  

  • 8. The drug bill.
    Health Serv Manage; 1990 Oct; 86(5):204. PubMed ID: 10107160
    [No Abstract]   [Full Text] [Related]  

  • 9. David Haslam. Interview by Asher Mullard.
    Haslam D
    Nat Rev Drug Discov; 2013 Jul; 12(7):500. PubMed ID: 23764976
    [No Abstract]   [Full Text] [Related]  

  • 10. Using market-exclusivity incentives to promote pharmaceutical innovation.
    Kesselheim AS
    N Engl J Med; 2010 Nov; 363(19):1855-62. PubMed ID: 21047231
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulating the drugs industry transparently.
    Abraham J
    BMJ; 2005 Sep; 331(7516):528-9. PubMed ID: 16150745
    [No Abstract]   [Full Text] [Related]  

  • 12. Licensing and provision of medicines in the United Kingdom. An appraisal.
    Collier J
    Lancet; 1985 Aug; 2(8451):377-81. PubMed ID: 2862524
    [No Abstract]   [Full Text] [Related]  

  • 13. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
    Higgins MJ; Graham SJ
    Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944
    [No Abstract]   [Full Text] [Related]  

  • 14. Compensating the drug victim.
    Lancet; 1978 Jul; 2(8079):26. PubMed ID: 78220
    [No Abstract]   [Full Text] [Related]  

  • 15. New terms for the pharmaceutical price regulation scheme.
    Drug Ther Bull; 1993 Dec; 31(26):103-4. PubMed ID: 8306850
    [No Abstract]   [Full Text] [Related]  

  • 16. 1992 Le Tourneau Award. Problems with pharmaceutical regulation in the United States. Drug lag and orphan drugs.
    Henry V
    J Leg Med; 1993 Dec; 14(4):617-39. PubMed ID: 8308452
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug development, regulation, and the practice of medicine.
    Wardell WM
    JAMA; 1974 Sep; 229(11):1457-61. PubMed ID: 4408186
    [No Abstract]   [Full Text] [Related]  

  • 18. Patent watch: EPO rejects reach through claims.
    Nat Rev Drug Discov; 2010 Jan; 9(1):12. PubMed ID: 20043023
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of legislation on the introduction of drugs. Is there a drug lag?
    de Haen P
    Drug Intell Clin Pharm; 1976 Feb; 10(2):86-93. PubMed ID: 10236233
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug regulatory agencies: a Canadian perspective.
    Ling GM; Leger J
    Int J Clin Pharmacol; 1973 Jul; 7(4):348-54. PubMed ID: 4740790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.